Q4 2015 13F Holders as of 31 Dec 2015
-
Type / Class
-
Equity / COM NEW
-
Total 13F shares
-
63,922,752
-
Share change
-
-1,314,296
-
Total reported value
-
$362,290,644
-
Put/Call ratio
-
58%
-
Price per share
-
$5.67
-
Number of holders
-
128
-
Value change
-
-$6,850,019
-
Number of buys
-
61
-
Number of sells
-
55
Institutional Holders of SYNERGY PHARMACEUTICALS DEL - COM NEW (SGYPQ) as of Q4 2015
As of 31 Dec 2015,
SYNERGY PHARMACEUTICALS DEL - COM NEW (SGYPQ) was held by
128 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
63,922,752 shares.
The largest 10 holders included
PAULSON & CO. INC., VANGUARD GROUP INC, BlackRock Fund Advisors, STATE STREET CORP, MILLENNIUM MANAGEMENT LLC, BlackRock Institutional Trust Company, N.A., CITADEL ADVISORS LLC, ORBIMED ADVISORS LLC, Invesco Ltd., and FRANKLIN RESOURCES INC.
This page lists
128
institutional shareholders reporting positions in this security
for the Q4 2015 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.